28
EN
artyst NO.1
Please advise your clients to avoid con-
tact with recently treated skin as much
as possible. Recently treated areas of
skin should also be
O
protected against contamination and
O
UV radiation and sunlight
and additional irritants, such as
O
swimming pool or sauna visits,
O
abrasive or chemical peels,
O
hair removal at the treated areas or
O
self-tanning lotions
should be avoided in the first two to
three days after the treatment of the
client.
2.4
Contraindications and side
effects
The following contraindications and side
effects are the result of careful analysis
of clinical literature on micropigmenta-
tion. If the person responsible for treat-
ment should have even the slightest
doubt that the safety of the client to be
treated cannot be guaranteed, for exam-
ple due to accompanying illnesses, the
treatment must be refrained from or
stopped immediately.
2.4.1
Contraindications
Permanent make-up treatment is
not
permitted in case of the following condi-
tions:
O
Hemophilia or other blood coagulation
disorders
O
Current consumption of blood thinners
(e.g. acetylsalicylic acid, heparin, as-
pirin, warfarin)
O
Uncontrolled diabetes mellitus
O
Any form of active acne in the treat-
ment area
O
Dermatosis (e.g. skin tumors, keloids
or extreme inclination for keloid for-
mation, solar keratosis, warts and/or
moles) in the treatment area
O
Open wounds and/or eczema and/or
skin rashes in the treatment area
O
Scars in the treatment area
O
Systemic infections and infective dis-
eases (e.g. hepatitis A, B, C, D E or F;
HIV infection) or acute local skin infec-
tions (e.g. herpes, rosacea)
O
During chemotherapy, radiotherapy or
high-dosage corticosteroid therapy
(recommendation: less than 4 weeks
before the beginning until 4 weeks af-
ter the end of the therapy)
O
Up to 12 months after plastic surgery
in the treatment area
O
Up to 6 months after filler injections in
the treatment area
O
Allergy to topical anesthetics (local
anesthesia)
O
Under the influence of alcohol and/or
drugs
O
Pregnancy and lactation
Treatment of mucous membranes and
eyeballs is strictly prohibited.
The treatment must be terminated im-
mediately in the event of:
O
Excessive sensations of pain
O
Fainting / dizziness
In rare cases, the following problems can
be caused by the introduction of mi-
cropigmentation ink:
O
Color differences
O
Pigment loss
Содержание artyst NR.1
Страница 2: ...2 artyst NR 1 artyst NR 1 1 2 3 4 5 6 7 8...
Страница 123: ...123 ES artyst NR 1...
Страница 125: ...125 RU artyst NR 1 1 artyst NR 1 artyst O artyst O O 1 1 E...
Страница 126: ...126 RU artyst NR 1 E O 2 2 1 E E E E E E MT DERM GmbH 2 2 E E E E E E 4 1 132 4 2 133 8 142 E E 24 7 1 141...
Страница 127: ...127 RU artyst NR 1 2 3 E 5 5 138 E E E E E E Sharps E E E...
Страница 128: ...128 RU artyst NR 1 E 7 4 142 7 2 141 2 2 126 E E 6 3 140 E E O O O O O O 2 4 2 4 1 O...
Страница 129: ...129 RU artyst NR 1 O O O O O O O A D E F O O 12 O 6 O O O O O O O O 2 4 2 O O O 6 O 12 72 O 5 O 8...
Страница 130: ...130 RU artyst NR 1 O I HSV I O O O O O O O O 2 4 3 O O 6 3 140 O 2 3 127 O 2 4 1 128 2 4 2 129 2 5 2 5 1...
Страница 131: ...131 RU artyst NR 1 2 5 2 PMU O O O O 2 5 3 2 4 1 128 2 6 2014 35 2014 30 IP20 II...
Страница 134: ...134 RU artyst NR 1 E 4 3 133 E E E 3 10 C E 15 C 25 C 50 95 F 5 1 E E...
Страница 135: ...135 RU artyst NR 1 E E E b a d 90 c E E E...
Страница 136: ...136 RU artyst NR 1 E E E 90 E E E E E 5 2...
Страница 137: ...137 RU artyst NR 1 E 9 143 E E E E DC E 3 artyst 5 3 4 3 133 E Cinch 5 4 E...
Страница 138: ...138 RU artyst NR 1 5 5 E E E 7 2 141 E E 7 2 141 E E E 5 6 E E E 9 143 10 1 144...
Страница 139: ...139 RU artyst NR 1 E 6 6 1 E 5 2 136 E SPEED LEVEL 6 E RUN STOP 1 5 30 6 2 E...
Страница 142: ...142 RU artyst NR 1 O 10 10 10 O O O O 20 50 15 O O pH 7 O O 7 3 E 5 5 138 7 4 E 8 E E E E E...
Страница 144: ...144 RU artyst NR 1 10 10 1 MT DERM GmbH O DIN EN ISO 13485 2016 O O...